Home / Sponsor Opportunities - Citeline Pharma Intelligence Awards Japan 2023

Sponsor Opportunities - Citeline Pharma Intelligence Awards Japan 2023

Citeline
Hero banner for Citeline Japan Sponsorship page

Why sponsor?

Sponsoring the Citeline Pharma Intelligence Awards Japan is the most cost-effective way of consistently promoting your company to leaders in the biopharmaceuticals industry. Your investment allows you the exclusive opportunity to meet face-to-face with key contacts, whilst reinforcing your brand positioning throughout the year.

Demonstrate leadership and commitment to honoring the outstanding advancements and innovation in Japanese pharma and biotech by sponsoring these awards. You will also benefit from a high-impact, multichannel marketing campaign, pre, during and post awards.

 

KEY SPONSORSHIP BENEFITS

  Acquire a competitive advantage
  Network with key people within your industry

 

  Take advantage of unrivalled brand exposure

 

  Boost your competitive advantage
 Position your organization at the forefront of the industry, and strengthen relationships with the most prominent names in Japanese pharma and biotech
SPONSORING THE CITELINE PHARMA INTELLIGENCE AWARDS JAPAN

There are numerous sponsorship opportunities at the Citeline Pharma Intelligence Awards Japan including:

  • Headline Sponsorship
  • Category Sponsorship*
  • Drinks reception Sponsorship
  • Social media Sponsorship
  • Program & Guestlist Sponsorship

The Citeline Pharma Intelligence Awards Japan brings together over 200 individuals and teams with the best minds in pharma and biotech. With a captive audience of senior decision-makers, the awards offer a prime opportunity to amplify your organization’s message and generate new business

Previous attendees include:
  • Avance Clinical
  • CMIC
  • Daiichi-Sankyo
  • ICON
  • Parexel
  • Rakuten Medical
  • Sosei Heptares
  • Syneos Health
  • Takeda

As a sponsor, benefit from these promotions and more, ensuring your company receives maximum exposure to the industry:

  • Your company logo on all marketing collateral as sponsor
  • Your company logo on all Citeline Awards adverts
  • Company profile and logo on the Citeline Pharma Intelligence Awards Japan website
  • Social media announcements of your involvement
  • Your company mentioned in Citeline Awards email campaigns
  • Exclusive branded signage on the Awards night
  • Adverts in the official digital Awards Programme

We’ll work to find the most suitable sponsorship package for you. If you have a query regarding sponsorship, please contact Christopher Keeling at Tel: +44 (0) 7917 647 859 or Email: [email protected] for information.

  • Date: Thursday, 17 October, 2023
  • Location: The Palace Hotel, Tokyo, Japan
PREVIOUS SPONSORS OF THE CITELINE PHARMA INTELLIGENCE AWARDS JAPAN
CMIC
CMIC stands for Current Medical Information Center. In 1992, Dr. Kazuo Nakamura founded CMIC as the first Contract Research Organization (CRO) in Japan. CMIC Group is currently the largest clinical CRO in Japan, providing comprehensive services in drug development, clinical trial and clinical site management, clinical to commercial GMP manufacturing, regulatory consulting and contract sales & marketing solutions. We can help pharmaceutical, biotech and medical device companies to enter Japan market, to conduct clinical trials in Asia, or to bridge your drug development and manufacturing needs between the US and Japan. CMIC Group has over 7,000 employees and 25 sites globally.
ICON
ICON plc is a world-leading healthcare intelligence and clinical research organisation, with over 38,000 employees in 93 locations in 46 countries around the world, headquartered in Dublin. We advance clinical research by providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device, and government and public health organisations. Our services span the entire lifecycle of product development, from molecule to medicine, across a broad range of therapeutic areas. We develop new innovations, drive emerging therapies forward, and improve patient lives.
Avance Clinical
Avance Clinical is a premium full-service Contract Research Organisation (CRO) based in Australia, New Zealand and North America, providing high-quality clinical research services to the international drug development industry which brings innovative new drugs to patients. Avance Clinical has more than 260 staff and has backing from the private equity group, Riverside Company, to support global expansion plans.

Avance Clinical offers clinical project management, trial monitoring, regulatory support, safety reporting, scientific and medical writing, data management, statistical and pharmacokinetic services, and external clinical auditing. We operate to the highest standards of compliance required by global regulatory agencies such as the FDA to ensure acceptance of data for drug approvals.

Our clients are international biotech companies in their early phases of drug development that require fast, agile, and adaptive solution-oriented clinical research services. The company uses state-of-the-art technology, gold standard systems, and deep scientific expertise to provide clients with the most successful outcomes.

The Avance Clinical team offers exceptional study approval and success rates which can be attributed to its deep scientific expertise, advanced data technologies, knowledge of the Australian, New Zealand and North American regulatory environment, and its extensive relationships with sites and KOLs.
ICON
“This type of event makes us realize that what we do in our industry is real, not virtual. It is a great way to recognize all the positive impact we are making to people's lives.”
circular image frame Professionals submitting a form to find out more about Citeline.

Enquire about sponsoring